Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
AI and Precision Oncology: How Companion Diagnostics Save Lives
Imaging & Diagnostics AI and Precision Oncology: How Companion Diagnostics Save Lives

Companion diagnostics have revolutionized the field of precision oncology by enabling the identification of patients who will benefit most from targeted therapies. Focusing on the genetic and molecular characteristics of an individual's cancer, these diagnostics have significantly improved

How Can Veradigm Payer Insights Bridge Care Gaps in Healthcare?
Digital Health How Can Veradigm Payer Insights Bridge Care Gaps in Healthcare?

The modern healthcare system grapples with persistent challenges in identifying and closing care gaps for patients, which often leads to disappointing care quality and missed opportunities for improving patient outcomes. Providers frequently struggle to access comprehensive patient information,

Is J&J's $55 Billion U.S. Investment Changing Pharmaceutical Manufacturing?
Regulatory & Compliance Is J&J's $55 Billion U.S. Investment Changing Pharmaceutical Manufacturing?

Johnson & Johnson’s commitment to investing $55 billion in U.S. manufacturing, research, and development over the next four years marks a significant expansion for the renowned pharmaceutical company. Announced by CEO Joaquin Duato on March 21, this ambitious initiative is intended to bolster t

New PET Imaging Method Offers Insights into Long COVID's Impact
Imaging & Diagnostics New PET Imaging Method Offers Insights into Long COVID's Impact

A groundbreaking development in the realm of medical imaging is offering refreshing insights into the lingering effects of COVID-19, known as long COVID, which continues to affect countless individuals even after initial recovery. The new approach utilizes a specialized PET imaging method designed

Is 23andMe Bankruptcy a Genetic Data Privacy Risk for 15M Customers?
Regulatory & Compliance Is 23andMe Bankruptcy a Genetic Data Privacy Risk for 15M Customers?

23andMe’s weekend bankruptcy filing has ignited concerns among consumers who provided the company with their genetic information and reignited discussions on data privacy among policymakers and security experts. Among the genetic testing company’s assets is the genetic information of more than 15 mi

Llantrisant Health Park Proposed as Regional Medical Hub for South East Wales
Imaging & Diagnostics Llantrisant Health Park Proposed as Regional Medical Hub for South East Wales

The Llantrisant Health Park near the Royal Glamorgan Hospital is poised for a transformational role as a regional diagnostic and treatment center for patients in South East Wales. It will serve areas including Gwent, Cardiff, the Vale of Glamorgan, and the Glamorgan Valleys. Health officials are

Why Compliance Automation Is a Must for Healthcare
Editorial Why Compliance Automation Is a Must for Healthcare

Juggling clinical operations and a maze of legal mandates (from protecting patient records to navigating complex reimbursement protocols) increases the pressure on professionals in the IT industry.    One misstep could mean financial penalties, lawsuits, and lasting damage to your business’ cre

AI Promises Advanced EHR Systems for VA and DoD Despite Challenges
Digital Health AI Promises Advanced EHR Systems for VA and DoD Despite Challenges

Introduction Artificial Intelligence (AI) has significantly transformed various industries, and the integration of AI into Electronic Health Record (EHR) systems is revolutionizing healthcare delivery in the Veterans Administration (VA) and Department of Defense (DoD). Despite facing implementation

How Can RPM Technologies Transform Patient Retention and Care Capacity?
Patient Care How Can RPM Technologies Transform Patient Retention and Care Capacity?

Remote Patient Monitoring (RPM) technologies are making significant strides in leveraging cardiac data to address critical challenges within healthcare systems. As the diversity of healthcare options expands and patient volumes continue to rise, the focus on patient retention and capacity

What Are the Key Trends in Healthcare M&A for 2025?
Digital Health What Are the Key Trends in Healthcare M&A for 2025?

Amid a promising outlook, the healthcare sector is poised to experience significant M&A (mergers and acquisitions) activity in 2025. Private equity (PE) investment in healthcare is projected to rebound sharply, driven by factors such as expected stabilization in interest rates, increased demand

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later